Lecture 8: Vasoactive Peptides Flashcards
List the drug classes of Vasoactive Peptides (6)
- Renin Inhibitor
- Angiotensin-Converting Enzyme Inhibitors (ACEI)
- Angiotensin Receptor Blockers (ARBs)
- ET Receptor Antagonist
- Synthetic BNP Analog
- ARB+ Neprilysin Inhibitor
Which drug class(es) are the endogenous peptide of Angiotensin II? (3)
- Renin inhibitors
- ACEI
- ARBs
Which drug class(es) are the endogenous peptide of Endothelin 1 (1)
ET Receptor Antagonist
Which drug class(es) are the endogenous peptide of Natriuretic peptides? (1)
Synthethic BNP Analog
Which drug class(es) are the endogenous peptide of Angiotensin II/Natriuretic peptides? (1)
ARB + Neprilysin Inhbitor
Which drug(s) are Renin Inhibitor? (1)
Aliskiren
Which drug(s) are Angiotensin-Converting Enzyme Inhibitors (ACEI)? (6)
PRIL=ACEI
- Captopril
- Benazepril
- Enalapril
- Lisinopril
- Quinapril
- Ramipril
Which drug(s) are Angiotensin Receptors Blockers (ARBs)? (4)
Sartan=ARBs
- Candesartan
- Irbesartan
- Losartan
- Valsartan
Which drug(s) are ET Receptor Antagonist? (1)
Bosentan
Which drug(s) are Synthetic BNP Analog? (1)
Nesiritide
(Never use terrible side effects)
Which drug(s) are ARB+Neprilysin Inhibitor? (2)
Sacubitril and Valsartan
List some natural substances in our bodies that cause vasocontriction? (3)
- Endothelin
- Vasopressin
- Angiotensin II
List some natural substances in our bodies that cause vasodilation? (2)
- Bradykinin
- Natriuretic Peptides
How to vasoactive peptide drugs target vasoconstrictors and vasodilators in our body?
- Vasoconstrictors: Drugs BLOCK them to ↑ dilation
- Vasodilators: Drugs PROMOTE these to ↑ dilation
Vasoconstrictiors: Endothelin, Vasopressin, Angiotensin II
Vasodilators: Bradykinin, Natriuretic Peptides
Using the image below explain what occurs in the heart after hypertension, heart attack, etc that eventually leads to Heart Failure
- When a pt has HTN or heart attack the heart goes through remodeling (e.g. fiber tissue issues or RV issues)
- D/t remodeling the heart ability to get blood into the system is decreased
- The body believes the BP is low, so it activates the short term (baroreceptors) and long term (RAAS) feedback loops to help increase BP
- The effects occur (e.g. fluid retention by the RAAS pathway) but d/t remodeling the heart is not working properly
- These causes the feedback systems to activate again and again w/ the heart getting worst and eventually leading to worsening Heart Failure
RAAS pathway includes Renin, Angiotension and Aldosterone
What are the biological effects of Angiotensin II? (4)
When Angiotensin II is released:
- ↓ Natriuresis (Na+ in urine), ↑H2O reabsorption (d/t ↑ Aldosterone & Vasopressin (ADH))-Volume Expansion
- Release of Vasoconstrictors→Direct Vasconstriction
- ↑ Symphathetic Tone
- Cell Proliferation (Heart remodeling), Migration and Hypertrophy
Explain the short term and long term changes that occur d/t the release of Angiotensin II
- Short term: Release Ca2+ which causes contraction and excitation→Vasoconstriction
- Long-term: Activates Jak2 which causes Mitogenic effect→Genetic changes: Remodeling
What step in the Angiotensin II release pathway does the drug Aliskiren affect?
- Aliskiren is a renin inhibitor so it STOPS Angiotensinogen (secreted by liver) from turining into Angiotensin I
Angotensinogen is the first step of the RAAS pathway
What step in the Angiotensin II release pathway does ACEI affect?
-PRIL=ACE inhibitors
- STOPS Angiotensin I from converting to Angiotensin II by inhibiting ACE
- STOPS the breakdown of Bradykinin into compounds (PGE2, PGI2, NO, EDHF) that cause dilation by inhibiting ACE
- ACE= Angiotensin-Converting Enzyme
Which steps in the Angiotensin II release pathway does ARBs affect?
-Sartan= ARBs
- Blocks the Angiotensin II recptors that normally causes vasoconstriction and aldosterone secretion
- Vasoconstriction→↑ peripheral vascular resistance→↑BP
- Aldosterone secretion→↑Na+ secretion and H2O retention→↑BP
- ARBs block the receptors that cause the normal mechanism of increasing BP BUT do NOT affect Angiotensin II levels
ARBs= Angiotension Receptor Blockers
What are the Vascular effects of ACE-I and ARBs?
-PRIL: ACE-I
-Sartan: ARBs
- Vasorelaxation
- Decrease in arterial resistance
- Progressive reduction in BP (NO reflex tachy)
- Reverese hypertrophy
- Augument vascular distensibility
- Decrease oxidative stress (injury to blood vessels)
- Improved endothelial function
- Antiplatelet effect (ACE-I greater)
- Stabilizes Plaque
- ↓ Neutrophils and monocular cells Proliferation (Remodeling)
What are the Cardic effects of ACE-I and ARBs?
-PRIL: ACE-I
-Sartan: ARBs
- Decreased preload and afterload
- NO change, or an increase, in cardic ouput
- ↓ Aldosterone→ ↓BP; ↓ Angiotesin II→↓ remodeling: Reverse Hypertrophy